Three-Year Interim Results from a Post-Marketing Surveillance Study of Patients with Migraine Treated with Fremanezumab in South Korea - Top-Institutions - MDSpire

Three-Year Interim Results from a Post-Marketing Surveillance Study of Patients with Migraine Treated with Fremanezumab in South Korea

  • By

  • Dayoung Seo

  • Manho Kim

  • Mi Ji Lee

  • Min Kyung Chu

  • Soo-Jin Cho

  • Heui-Soo Moon

  • Tae-Jin Song

  • Soohyun Cho

  • Byung-Kun Kim

  • Gabriela Kivelevitch

  • July 6, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Seoul National University Hospital
    Seoul National University Hospital

    Seoul, South Korea

    Key Differentiators

    • Neurology
    • Headache Management

  • #2

    Severance Hospital, Yonsei University Health System
    Severance Hospital, Yonsei University Health System

    Seoul, South Korea

    Key Differentiators

    • Neurology
    • Migraine Research

  • #3

    Ewha Womans University Mokdong Hospital
    Ewha Womans University Mokdong Hospital

    Seoul, South Korea

    Key Differentiators

    • Neurology
    • Headache Management

Original Source(s)

Three-Year Interim Results from a Post-Marketing Surveillance Study of Patients with Migraine Treated with Fremanezumab in South Korea

  • by Dayoung Seo, Manho Kim, Mi Ji Lee, Min Kyung Chu, Soo-Jin Cho, Heui-Soo Moon, Tae-Jin Song, Soohyun Cho, Byung-Kun Kim, Gabriela Kivelevitch

  • July 6, 2026

Related Content

Dynamic activation of lytic cell death-related programs identifies CD14 as a candidate hub gene associated with secondary injury after spinal cord injury

Intraoperative technological advances and new frontiers in precision glioma surgery

Advances in the multimodal management of central nervous system solitary fibrous tumors